{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:53:39Z","timestamp":1795125219102,"version":"4.10.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","award":["BRG6080004"],"award-info":[{"award-number":["BRG6080004"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      has emerged as one of the common multidrug resistance pathogens causing hospital-acquired infections. This study was conducted to elucidate the distribution of antimicrobial resistance genes in the bacterial population in Thailand. Multidrug-resistant\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      (MDR\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      ) isolates were characterized phenotypically, and the molecular epidemiology of clinical isolates in 11 tertiary hospitals was investigated at a country-wide level.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 135 nonrepetitive MDR\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      isolates collected from tertiary care hospitals across 5 regions of Thailand were examined for antibiotic susceptibility, resistance genes, and sequence types. Multilocus sequence typing (MLST) was performed to characterize the spread of regional lineages.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      ST2 belonging to IC2 was the most dominant sequence type in Thailand (65.19%), and to a lesser extent, there was also evidence of the spread of ST164 (10.37%), ST129 (3.70%), ST16 (2.96%), ST98 (2.96%), ST25 (2.96%), ST215 (2.22%), ST338 (1.48%), and ST745 (1.48%). The novel sequence types ST1551, ST1552, ST1553, and ST1557 were also identified in this study. Among these, the\n                      <jats:italic>bla<\/jats:italic>\n                      oxa-23 gene was by far the most widespread in MDR\n                      <jats:italic>A. baumannii,<\/jats:italic>\n                      while the\n                      <jats:italic>bla<\/jats:italic>\n                      oxa-24\/40 and\n                      <jats:italic>bla<\/jats:italic>\n                      oxa-58 genes appeared to be less dominant in this region. The results demonstrated that the predominant class D carbapenemase was\n                      <jats:italic>bla<\/jats:italic>\n                      OXA-23, followed by the class B carbapenemase\n                      <jats:italic>bla<\/jats:italic>\n                      NDM-like, while the\n                      <jats:italic>mcr<\/jats:italic>\n                      -1 gene was not observed in any isolate. Most of the MDR\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      isolates were resistant to ceftazidime (99.23%), gentamicin (91.85%), amikacin (82.96%), and ciprofloxacin (97.78%), while all of them were resistant to carbapenems. The results suggested that colistin could still be effective against MDR\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      in this region.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This is the first molecular epidemiological analysis of MDR\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      clinical isolates at the national level in Thailand to date. Studies on the clonal relatedness of MDR\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      isolates could generate useful data to understand the local epidemiology and international comparisons of nosocomial outbreaks.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12941-021-00424-z","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T13:02:33Z","timestamp":1616245353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: a nationwide study"],"prefix":"10.1186","volume":"20","author":[{"given":"Piyatip","family":"Khuntayaporn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pohnvipa","family":"Kanathum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jantana","family":"Houngsaitong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preecha","family":"Montakantikul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krit","family":"Thirapanmethee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mullika Traidej","family":"Chomnawang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,20]]},"reference":[{"key":"424_CR1","unstructured":"O'Neill J. Review on antimicrobial resistance: Tackling a crisis for the health and wealth of nations. London: Review on antimicrobial resistance. 2014. https:\/\/amr-review.org\/sites\/default\/files\/160518_Final%20paper_with%20cover.pdf"},{"key":"424_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","volume":"10","author":"MS Mulani","year":"2019","unstructured":"Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR. Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review. Front Microbiol. 2019;10:539. https:\/\/doi.org\/10.3389\/fmicb.2019.00539.","journal-title":"Front Microbiol"},{"key":"424_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.21037\/jeccm.2018.11.08","volume":"2","author":"M Tosi","year":"2018","unstructured":"Tosi M, Roa E, De Biasi S, Munari E, Venturelli S, Coloretti I, Biagioni E, Cossarizza A, Girardis M. Multidrug resistant bacteria in critically ill patients: a step further antibiotic therapy. J Emerg Crit Care Med. 2018;2:103. https:\/\/doi.org\/10.21037\/jeccm.2018.11.08.","journal-title":"J Emerg Crit Care Med"},{"issue":"3","key":"424_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/antibiotics9030119","volume":"9","author":"CA Moubareck","year":"2020","unstructured":"Moubareck CA, Halat DH. Insights into Acinetobacter baumannii: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen. Antibiotics (Basel). 2020;9(3):119. https:\/\/doi.org\/10.3390\/antibiotics9030119.","journal-title":"Antibiotics (Basel)"},{"issue":"3","key":"424_CR5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1128\/CMR.00058-07","volume":"21","author":"AY Peleg","year":"2008","unstructured":"Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538\u201382. https:\/\/doi.org\/10.1128\/CMR.00058-07.","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl4","key":"424_CR6","first-page":"S34","volume":"92","author":"S Dejsirilert","year":"2009","unstructured":"Dejsirilert S, Tiengrim S, Sawanpanyalert P, Aswapokee N, Malathum K. Antimicrobial resistance of Acinetobacter baumannii: six years of National Antimicrobial Resistance Surveillance Thailand (NARST) surveillance. J Med Assoc Thai. 2009;92(Suppl4):S34\u201345 (PMID: 21294501).","journal-title":"J Med Assoc Thai."},{"key":"424_CR7","unstructured":"National Institute of Health, Department of Medical Sciences, Thailand. Antibiograms. National Antimicrobial Resistance Surveillance Center, Thailand (NARST). http:\/\/narst.dmsc.moph.go.th\/antibiograms.html. Accessed 6 Jan 2021."},{"key":"424_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40560-015-0077-4","volume":"3","author":"J Inchai","year":"2015","unstructured":"Inchai J, Pothirat C, Bumroongkit C, Limsukon A, Khositsakulchai W, Liwsrisakun C. Prognostic factors associated with mortality of drug-resistant Acinetobacter baumanniiventilator-associated pneumonia. J Intensive Care. 2015;3:9. https:\/\/doi.org\/10.1186\/s40560-015-0077-4.","journal-title":"J Intensive Care."},{"issue":"Suppl4","key":"424_CR9","first-page":"S91","volume":"92","author":"A Apisarnthanarak","year":"2009","unstructured":"Apisarnthanarak A, Buppunharun W, Tiengrim S, Sawanpanyalert P, Aswapokee N. An overview of antimicrobial susceptibility patterns for gram-negative bacteria from the National Antimicrobial Resistance Surveillance Thailand (NARST) program from 2000 to 2005. J Med Assoc Thai. 2009;92(Suppl4):S91\u20134 (PMID: 21298849).","journal-title":"J Med Assoc Thai."},{"issue":"6","key":"424_CR10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ajic.2008.10.024","volume":"37","author":"A Apisarnthanarak","year":"2009","unstructured":"Apisarnthanarak A, Mundy LM. Mortality associated with Pandrug-resistant Acinetobacter baumannii infections in Thailand. Am J Infect Control. 2009;37(6):519\u201320. https:\/\/doi.org\/10.1016\/j.ajic.2008.10.024.","journal-title":"Am J Infect Control"},{"key":"424_CR11","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1128\/JCM.43.9.4382-4390.2005","volume":"43","author":"SG Bartual","year":"2005","unstructured":"Bartual SG, Seifert H, Hippler C, Luzon MA, Wisplinghoff H, Rodriquez-Valera F. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol. 2005;43:4382\u201390. https:\/\/doi.org\/10.1128\/JCM.43.9.4382-4390.2005.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"424_CR12","doi-asserted-by":"publisher","first-page":"e10034","DOI":"10.1371\/journal.pone.0010034","volume":"5","author":"L Diancourt","year":"2010","unstructured":"Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS ONE. 2010;5(4):e10034. https:\/\/doi.org\/10.1371\/journal.pone.0010034.","journal-title":"PLoS ONE"},{"key":"424_CR13","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3389\/fmicb.2019.00930","volume":"10","author":"S Gaiarsa","year":"2019","unstructured":"Gaiarsa S, Biffignandi GB, Esposito EP, Castelli M, Jolley KA, Brisse S, Sassera D, Zarrilli R. Comparative analysis of the two Acinetobacter baumannii multilocus sequence typing (MLST) schemes. Front Microbiol. 2019;10:930. https:\/\/doi.org\/10.3389\/fmicb.2019.00930.","journal-title":"Front Microbiol"},{"issue":"8","key":"424_CR14","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1128\/JCM.01021-06","volume":"44","author":"JF Turton","year":"2006","unstructured":"Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol. 2006;44(8):2974\u20136. https:\/\/doi.org\/10.1128\/JCM.01021-06.","journal-title":"J Clin Microbiol."},{"key":"424_CR15","unstructured":"Clinical and Laboratory Standards Institute. performance standards for antimicrobial susceptibility testing, 30th CLSI Document M100. Clinical and Laboratory Standards Institute: Wayne, PA; 2016"},{"issue":"3","key":"424_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x.","journal-title":"Clin Microbiol Infect."},{"issue":"2","key":"424_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3947\/ic.2019.51.2.107","volume":"51","author":"P Khuntayaporn","year":"2019","unstructured":"Khuntayaporn P, Yamprayoonswat W, Yasawong M, Chomnawang MT. Dissemination of Carbapenem-Resistance among multidrug resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes, including the novel blaIMP-65 gene in Thailand. Infect Chemother. 2019;51(2):107\u201318. https:\/\/doi.org\/10.3947\/ic.2019.51.2.107.","journal-title":"Infect Chemother"},{"key":"424_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","volume":"70","author":"L Poirel","year":"2011","unstructured":"Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70:119\u201323. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2010.12.002.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"424_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.12688\/wellcomeopenres.14826.1","volume":"3","author":"KA Jolley","year":"2018","unstructured":"Jolley KA, Bray JE, Maiden MCJ. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res. 2018;3:124. https:\/\/doi.org\/10.12688\/wellcomeopenres.14826.1.","journal-title":"Wellcome Open Res."},{"key":"424_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1471-2105-10-152","volume":"10","author":"AP Francisco","year":"2009","unstructured":"Francisco AP, Bugalho M, Ramirez M, Carri\u00e7o JA. Global optimal eBURST analysis of multilocus typing data using a graphic matroid approach. BMC Bioinform. 2009;10:152. https:\/\/doi.org\/10.1186\/1471-2105-10-152.","journal-title":"BMC Bioinform"},{"key":"424_CR21","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00134-015-4079-4","volume":"41","author":"J Garnacho-Montero","year":"2015","unstructured":"Garnacho-Montero J, Dimopoulos G, Poulakou G, Akova M, Cisneros JM, Waele JD, Petrosillo N, Seifert H, Timsit JF, Vila J, Zahar JR, Bassetti M. Task force on management and prevention of Acinetobacter baumannii infections in the ICU. Intens Care Med. 2015;41:2057\u201375. https:\/\/doi.org\/10.1007\/s00134-015-4079-4.","journal-title":"Intens Care Med"},{"issue":"3","key":"424_CR22","doi-asserted-by":"publisher","first-page":"100077","DOI":"10.1016\/j.infpip.2020.100077","volume":"2","author":"SE Weinberg","year":"2020","unstructured":"Weinberg SE, Villedieu A, Bagdasarian N, Karah N, Teare L, Elamin WF. Control and management of multidrug resistant Acinetobacter baumannii: A review of the evidence and proposal of novel approaches. Infect Prev Pract. 2020;2(3):100077. https:\/\/doi.org\/10.1016\/j.infpip.2020.100077.","journal-title":"Infect Prev Pract"},{"key":"424_CR23","doi-asserted-by":"publisher","first-page":"787","DOI":"10.12998\/wjcc.v2.i12.787","volume":"2","author":"MF Lin","year":"2014","unstructured":"Lin MF, Lan CY. Antimicrobial resistance in Acinetobacter baumannii: from bench to bedside. World J Clin Cases. 2014;2:787\u2013814. https:\/\/doi.org\/10.12998\/wjcc.v2.i12.787.","journal-title":"World J Clin Cases"},{"key":"424_CR24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12879-019-4073-5","volume":"19","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Hu K, Zhang J, Guo Y, Fan X, Wang Y, Mensah SD, Zhang X. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in ICU of the eastern Heilongjiang Province. China BMC Infect Dis. 2019;19:452. https:\/\/doi.org\/10.1186\/s12879-019-4073-5.","journal-title":"China BMC Infect Dis"},{"key":"424_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3201\/eid1601.090852T","volume":"16","author":"PD Mugnier","year":"2010","unstructured":"Mugnier PD, Poirel L, Naas T, Nordmann P. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis. 2010;16:35\u201340. https:\/\/doi.org\/10.3201\/eid1601.090852T.","journal-title":"Emerg Infect Dis"},{"key":"424_CR26","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3390\/antibiotics9120864","volume":"9","author":"K Thirapanmethee","year":"2020","unstructured":"Thirapanmethee K, Srisiri-a-nun T, Houngsaitong J, Montakantikul P, Khuntayaporn P, Chomnawang MT. Prevalence of OXA-type \u03b2-lactamase genes among carbapenem-resistant Acinetobacter baumannii clinical isolates in Thailand. Antibiotics (Basel). 2020;9:864. https:\/\/doi.org\/10.3390\/antibiotics9120864.","journal-title":"Antibiotics (Basel)"},{"key":"424_CR27","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s12879-018-3359-3","volume":"18","author":"Y Chen","year":"2018","unstructured":"Chen Y, Yang Y, Liu L, Qiu G, Han X, Tian S, Zhao J, Chen F, Grundmann H, Li H, Sun J, Han L. High prevalence and clonal dissemination of OXA-72-producing Acinetobacter baumannii in a Chinese hospital: a cross sectional study. BMC Infect Dis. 2018;18:491. https:\/\/doi.org\/10.1186\/s12879-018-3359-3.","journal-title":"BMC Infect Dis"},{"key":"424_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s13353-021-00612-9","author":"I Goic-Barisic","year":"2021","unstructured":"Goic-Barisic I, Kovacic A, Medic D, Jakovac S, Petrovic T, Tonkic M, Novak A, Rubic Z, Radic M, Milosavljevi\u0107 B, Hrenovic J. Endemicity of OXA-23 and OXA-72 in clinical isolates of Acinetobacter baumannii from three neighbouring countries in Southeast Europe. J Appl Genet. 2021. https:\/\/doi.org\/10.1007\/s13353-021-00612-9.","journal-title":"J Appl Genet"},{"issue":"10","key":"424_CR29","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.1128\/AAC.01016-16","volume":"60","author":"L Dortet","year":"2016","unstructured":"Dortet L, Bonnin RA, Bernabeu S, Escaut L, Vittecoq D, Girlich D, Imanci D, Fortineau N, Naas T. First occurrence of OXA-72-producing Acinetobacter baumannii in Serbia. Antimicrob Agents Chemother. 2016;60(10):5724\u201330. https:\/\/doi.org\/10.1128\/AAC.01016-16.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"424_CR30","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1128\/AAC.01212-13","volume":"58","author":"T Tada","year":"2014","unstructured":"Tada T, Miyoshi-Akiyama T, Shimada K, Shimojima M, Kirikae T. Dissemination of 16S rRNA methylase ArmA-producing Acinetobacter baumannii and emergence of OXA-72 carbapenemase coproducers in Japan. Antimicrob Agents Chemother. 2014;58(5):2916\u201320. https:\/\/doi.org\/10.1128\/AAC.01212-13.","journal-title":"Antimicrob Agents Chemother"},{"key":"424_CR31","doi-asserted-by":"publisher","first-page":"249856","DOI":"10.1155\/2014\/249856","volume":"2014","author":"L Dortet","year":"2014","unstructured":"Dortet L, Poirel L, Nordmann P. Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria. Biomed Res Int. 2014;2014:249856. https:\/\/doi.org\/10.1155\/2014\/249856.","journal-title":"Biomed Res Int"},{"issue":"11","key":"424_CR32","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1093\/jac\/dks267","volume":"67","author":"B Rimrang","year":"2012","unstructured":"Rimrang B, Chanawong A, Lulitanond A, Wilailuckana C, Charoensri N, Sribenjalux P, Phumsrikaew W, Wonglakorn L, Kerdsin A, Chetchotisakd P. Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand. J Antimicrob Chemother. 2012;67(11):2626\u201330. https:\/\/doi.org\/10.1093\/jac\/dks267.","journal-title":"J Antimicrob Chemother."},{"issue":"1","key":"424_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1089\/mdr.2016.0248","volume":"24","author":"U Leungtongkam","year":"2018","unstructured":"Leungtongkam U, Thummeepak R, Wongprachan S, Thongsuk P, Kitti T, Ketwong K, Runcharoen C, Chantratita N, Sitthisak S. Dissemination of blaOXA-23, blaOXA-, blaOXA-58, and blaNDM-1 genes of Acinetobacter baumannii isolates from four tertiary hospitals in Thailand. Microb Drug Resist. 2018;24(1):55\u201362. https:\/\/doi.org\/10.1089\/mdr.2016.0248.","journal-title":"Microb Drug Resist."},{"issue":"2","key":"424_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","volume":"16","author":"YY Liu","year":"2016","unstructured":"Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, Yu LF, Gu D, Ren H, Chen X, Lu L, He D, Zhou H, Liang Z, Liu JH, Shen J. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161\u20138. https:\/\/doi.org\/10.1016\/S1473-3099(15)00424-7.","journal-title":"Lancet Infect Dis."},{"key":"424_CR35","doi-asserted-by":"publisher","first-page":"30280","DOI":"10.2807\/1560-7917.ES.2016.21.27.30280","volume":"21","author":"BB Xavier","year":"2016","unstructured":"Xavier BB, Lammens C, Ruhal R, Kumar-Singh S, Butaye P, Goossens H, Malhotra-Kumar S. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro Surveill. 2016;21:30280. https:\/\/doi.org\/10.2807\/1560-7917.ES.2016.21.27.30280.","journal-title":"Euro Surveill"},{"key":"424_CR36","doi-asserted-by":"publisher","first-page":"e00543","DOI":"10.1128\/mBio.00543-17","volume":"8","author":"W Yin","year":"2017","unstructured":"Yin W, Li H, Shen Y, Liu Z, Wang S, Shen Z, Zhang R, Walsh TR, Shen J, Wang Y. Novel plasmid-mediated colistin resistance gene mcr-3 in Escherichia coli. MBio. 2017;8:e00543-e617. https:\/\/doi.org\/10.1128\/mBio.00543-17.","journal-title":"MBio"},{"key":"424_CR37","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1093\/jac\/dkx327","volume":"72","author":"M Borowiak","year":"2017","unstructured":"Borowiak M, Fischer J, Hammer JA, Hendriksen RS, Szabo I, Malorny B. Identification of a novel transposon-associated phosphoethanolamine transferase gene, mcr-5, conferring colistin resistance in d-tartrate fermenting Salmonella enterica subsp. enterica serovar Paratyphi B. J Antimicrob Chemother. 2017;72:3317\u201324. https:\/\/doi.org\/10.1093\/jac\/dkx327.","journal-title":"J Antimicrob Chemother."},{"key":"424_CR38","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41426-018-0124-z","volume":"7","author":"X Wang","year":"2018","unstructured":"Wang X, Wang Y, Zhou Y, Li J, Yin W, Wang S, Zhang S, Shen J, Shen Z, Wang Y. Emergence of a novel mobile colistin resistance gene, mcr-8, in NDM-producing Klebsiella pneumoniae. Emerg Microbes Infect. 2018;7:122. https:\/\/doi.org\/10.1038\/s41426-018-0124-z.","journal-title":"Emerg Microbes Infect"},{"key":"424_CR39","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/jac\/dks084","volume":"67","author":"Y Cai","year":"2012","unstructured":"Cai Y, Chai D, Wang R, Liang B, Bai N. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother. 2012;67:1607\u201315. https:\/\/doi.org\/10.1093\/jac\/dks084.","journal-title":"J Antimicrob Chemother"},{"key":"424_CR40","unstructured":"The Public databases for molecular typing and microbial genome diversity (PubMLST). https:\/\/pubmlst.org\/organisms\/acinetobacter-baumannii. Accessed 6 Jan 2021."},{"key":"424_CR41","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.drup.2012.06.001","volume":"15","author":"N Karah","year":"2012","unstructured":"Karah N, Sundsfjord A, Towner K, Samuelsen O. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist Updat. 2012;15:237\u201347. https:\/\/doi.org\/10.1016\/j.drup.2012.06.001.","journal-title":"Drug Resist Updat"},{"key":"424_CR42","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1128\/JCM.34.6.1519-1525.1996","volume":"34","author":"L Dijkshoorn","year":"1996","unstructured":"Dijkshoorn L, Aucken H, Gerner-Smidt P, Janssen P, Kaufmann ME, Garaizar J, Ursing J, Pitt TL. Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol. 1996;34:1519\u201325. https:\/\/doi.org\/10.1128\/JCM.34.6.1519-1525.1996.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"424_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12866-019-1401-2","volume":"19","author":"T Nawfal Dagher","year":"2019","unstructured":"Nawfal Dagher T, Al-Bayssari C, Chabou S, Antar N, Diene SM, Azar E, Rolain JM. Investigation of multidrug-resistant ST2 Acinetobacter baumannii isolated from Saint George hospital in Lebanon. BMC Microbiol. 2019;19(1):29. https:\/\/doi.org\/10.1186\/s12866-019-1401-2.","journal-title":"BMC Microbiol"},{"key":"424_CR44","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3389\/fmicb.2015.00910","volume":"6","author":"Y Chang","year":"2015","unstructured":"Chang Y, Luan G, Xu Y, Wang Y, Shen M, Zhang C, Zheng W, Huang J, Yang J, Jia X, Ling B. Characterization of carbapenem-resistant Acinetobacter baumannii isolates in a Chinese teaching hospital. Front Microbiol. 2015;6:910. https:\/\/doi.org\/10.3389\/fmicb.2015.00910.","journal-title":"Front Microbiol"},{"issue":"2","key":"424_CR45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.diagmicrobio.2018.01.008","volume":"91","author":"U Singkham-In","year":"2018","unstructured":"Singkham-In U, Chatsuwan T. In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates. Diagn Microbiol Infect Dis. 2018;91(2):169\u201374. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.01.008.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"424_CR46","doi-asserted-by":"publisher","first-page":"5239","DOI":"10.1128\/AAC.00633-13","volume":"57","author":"DH Kim","year":"2013","unstructured":"Kim DH, Choi JY, Kim HW, Kim SH, Chung DR, Peck KR, Thamlikitkul V, So TM, Yasin RMD, Hsueh PR, Carlos CC, Hsu LY, Buntaran L, Lalitha MK, Song JH, Ko KS. Spread of carbapenem-resistant Acinetobacter baumannii global clone 2 in Asia and abaR-type resistance islands. Antimicrob Agents Chemother. 2013;57(11):5239\u201346. https:\/\/doi.org\/10.1128\/AAC.00633-13.","journal-title":"Antimicrob Agents Chemother"},{"key":"424_CR47","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3389\/fmicb.2020.00548","volume":"11","author":"J Loraine","year":"2020","unstructured":"Loraine J, Heinz E, Soontarach R, Blackwell GA, Stabler RA, Voravuthikunchai SP, Srimanote P, Kiratisin P, Thomson NR, Taylor PW. Genomic and phenotypic analyses of Acinetobacter baumannii isolates from three tertiary care hospitals in Thailand. Front Microbiol. 2020;11:548. https:\/\/doi.org\/10.3389\/fmicb.2020.00548.","journal-title":"Front Microbiol"},{"key":"424_CR48","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jgar.2020.02.011","volume":"22","author":"T Tada","year":"2020","unstructured":"Tada T, Uchida H, Hishinuma T, Watanabe S, Tohya M, Kuwahara-Arai K, Mya S, Zan KN, Kirikae T, Tin HH. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates from hospitals in Myanmar. J Glob Antimicrob Resist. 2020;22:122\u20135. https:\/\/doi.org\/10.1016\/j.jgar.2020.02.011.","journal-title":"J Glob Antimicrob Resist"},{"key":"424_CR49","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3389\/fmicb.2019.00593","volume":"10","author":"P Villal\u00f3n","year":"2019","unstructured":"Villal\u00f3n P, Ortega M, S\u00e1ez-Nieto JA, Carrasco G, Medina-Pascual MJ, Garrido N, Valdezate S. Dynamics of a sporadic nosocomial Acinetobacter calcoaceticus\u2014Acinetobacter baumannii complex population. Front Microbiol. 2019;10:593. https:\/\/doi.org\/10.3389\/fmicb.2019.00593.","journal-title":"Front Microbiol"},{"key":"424_CR50","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3389\/fmicb.2016.01687","volume":"7","author":"M Jiang","year":"2016","unstructured":"Jiang M, Liu L, Ma Y, Zhang Z, Li N, Zhang F, Zhao S. Molecular epidemiology of multi-drug resistant Acinetobacter baumannii isolated in Shandong. China Front Microbiol. 2016;7:1687. https:\/\/doi.org\/10.3389\/fmicb.2016.01687.","journal-title":"China Front Microbiol"},{"key":"424_CR51","doi-asserted-by":"publisher","first-page":"5021064","DOI":"10.1155\/2020\/5021064","volume":"2020","author":"M Rao","year":"2020","unstructured":"Rao M, Rashid F, Shukor S, Hashim R, Ahmad N. Detection of antimicrobial resistance genes associated with carbapenem resistance from the whole-genome sequence of Acinetobacter baumannii isolates from Malaysia. Can J Infect Dis Med. 2020;2020:5021064. https:\/\/doi.org\/10.1155\/2020\/5021064.","journal-title":"Can J Infect Dis Med"},{"key":"424_CR52","doi-asserted-by":"publisher","unstructured":"Schultz MB, Pham Thanh D, Tran Do Hoan N, Wick RR, Ingle DJ, Hawkey J, Edwards DJ, Kenyon JJ, Phu Huong Lan N, Campbell JI, Thwaites G, Thi Khanh Nhu N, Hall RM, Fournier-Level A, Baker S, Holt KE. Repeated local emergence of carbapenem-resistant Acinetobacter baumannii in a single hospital ward. Microb Genom. 2016;2:e000050. doi: https:\/\/doi.org\/10.1099\/mgen.0.000050.","DOI":"10.1099\/mgen.0.000050"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-021-00424-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12941-021-00424-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-021-00424-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T13:04:16Z","timestamp":1616245456000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-021-00424-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,20]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["424"],"URL":"https:\/\/doi.org\/10.1186\/s12941-021-00424-z","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,20]]},"assertion":[{"value":"25 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Review Committee, Faculty of Dentistry and Faculty of Pharmacy, Mahidol University (MU-DT\/PY-IRB 2016\/008.0404).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}